RD Biomed

RD Biomed is a UK-based medical technology company that specializes in the development and manufacture of non-invasive diagnostic solutions for gastroenterology. The company's flagship product, Peptest, is a rapid in-vitro diagnostic test designed to detect the presence of pepsin, a gastric enzyme, in clinical samples such as saliva and sputum. This serves as a reliable biomarker for diagnosing gastro-oesophageal reflux disease (GORD) and laryngopharyngeal reflux (LPR), often referred to as "silent reflux." RD Biomed's technology is utilized globally by clinicians in ENT, respiratory, and pediatric medicine to provide a cost-effective alternative to invasive procedures like endoscopy. The company maintains a strong international presence through strategic distribution partnerships in major markets, including China and the United States.